DK0981529T3 - Hidtil ukendt fremgangsmåde til fremstilling af farmakologisk aktivt stof - Google Patents

Hidtil ukendt fremgangsmåde til fremstilling af farmakologisk aktivt stof

Info

Publication number
DK0981529T3
DK0981529T3 DK98921670T DK98921670T DK0981529T3 DK 0981529 T3 DK0981529 T3 DK 0981529T3 DK 98921670 T DK98921670 T DK 98921670T DK 98921670 T DK98921670 T DK 98921670T DK 0981529 T3 DK0981529 T3 DK 0981529T3
Authority
DK
Denmark
Prior art keywords
preparation
active substance
pharmacologically active
hitherto unknown
unknown process
Prior art date
Application number
DK98921670T
Other languages
English (en)
Inventor
Maria Bakonyi
Nagy Marianna Csatarine
Leventene Molnar
Antal Gajary
Edit Alattyani
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of DK0981529T3 publication Critical patent/DK0981529T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DK98921670T 1997-05-13 1998-05-11 Hidtil ukendt fremgangsmåde til fremstilling af farmakologisk aktivt stof DK0981529T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9700885A HU222283B1 (hu) 1997-05-13 1997-05-13 Eljárás tieno[3,2-c]piridin-származékok előállítására
PCT/HU1998/000048 WO1998051689A1 (en) 1997-05-13 1998-05-11 A new process for the preparation of a pharmacologically active substance

Publications (1)

Publication Number Publication Date
DK0981529T3 true DK0981529T3 (da) 2002-04-22

Family

ID=90014236

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98921670T DK0981529T3 (da) 1997-05-13 1998-05-11 Hidtil ukendt fremgangsmåde til fremstilling af farmakologisk aktivt stof

Country Status (38)

Country Link
US (1) US6180793B1 (da)
EP (1) EP0981529B1 (da)
KR (1) KR100428238B1 (da)
CN (1) CN1109036C (da)
AR (1) AR014349A1 (da)
AT (1) ATE212025T1 (da)
AU (1) AU735702B2 (da)
BR (1) BR9809112B1 (da)
CA (1) CA2289623C (da)
CO (1) CO4950564A1 (da)
CZ (1) CZ292820B6 (da)
DE (1) DE69803176T2 (da)
DK (1) DK0981529T3 (da)
DZ (1) DZ2487A1 (da)
EE (1) EE03925B1 (da)
EG (1) EG21973A (da)
ES (1) ES2172141T3 (da)
HK (1) HK1027350A1 (da)
HR (1) HRP980240B1 (da)
HU (1) HU222283B1 (da)
ID (1) ID23018A (da)
IL (1) IL132774A0 (da)
IS (1) IS1883B (da)
ME (1) ME01636B (da)
MY (1) MY121299A (da)
NO (1) NO325419B1 (da)
NZ (1) NZ501577A (da)
PL (1) PL194859B1 (da)
PT (1) PT981529E (da)
RS (1) RS49626B (da)
RU (1) RU2172315C1 (da)
SA (1) SA98190583B1 (da)
SK (1) SK283700B6 (da)
TR (1) TR199902783T2 (da)
TW (1) TW552263B (da)
UA (1) UA66359C2 (da)
WO (1) WO1998051689A1 (da)
ZA (1) ZA983921B (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2769313B1 (fr) * 1997-10-06 2000-04-21 Sanofi Sa Derives d'esters hydroxyacetiques, leur procede de preparation et leur utilisation comme intermediaires de synthese
HU226421B1 (en) * 1998-11-09 2008-12-29 Sanofi Aventis Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides
IN191030B (da) * 2001-01-24 2003-09-13 Cadila Healthcare Ltd
US6495691B1 (en) 2001-07-06 2002-12-17 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
ITMI20020933A1 (it) * 2002-05-03 2003-11-03 Danimite Dipharma S P A Procedimento per la sintesi di clopidogrel
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US6800759B2 (en) 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
US6812363B2 (en) * 2002-10-15 2004-11-02 Usv Limited Racemization of optically active 2-substituted phenyl glycine esters
US20060100231A1 (en) * 2003-03-10 2006-05-11 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
EP1603920A1 (en) 2003-03-12 2005-12-14 Cadila Healthcare Ltd. Polymorph and amorphous form of (s)-(+)-clopidogrel bisulfate
GB0321256D0 (en) * 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
EP1680430B1 (en) 2003-11-03 2010-01-20 Cadila Healthcare Ltd. Processes for preparing form i of (s)-(+)- clopidogrel bisulfate
CA2457459A1 (en) * 2004-02-11 2005-08-11 Brantford Chemicals Inc. Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate
KR100553398B1 (ko) * 2004-03-12 2006-02-16 한미약품 주식회사 티에노[3,2-ｃ]피리딘 유도체의 제조 방법 및 이에사용되는 중간체
US20060154957A1 (en) * 2004-09-21 2006-07-13 Nina Finkelstein Crystalline clopidogrel hydrobromide and processes for preparation thereof
TW200640932A (en) * 2005-02-24 2006-12-01 Teva Pharma Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
KR100681512B1 (ko) 2005-03-08 2007-02-09 주식회사 한서켐 클로피도그렐의 신규한 제조 중간체 및 이를 이용한 클로피도그렐의 제조방법
KR101235117B1 (ko) 2005-12-26 2013-02-20 에스케이케미칼주식회사 광학분리에 의한 (ｓ)-(＋)-클로피도그렐의 제조방법
KR20090013794A (ko) * 2006-04-27 2009-02-05 인드-스위프트 래버러토리즈 리미티드 클로피도그렐 히드로겐 설페이트의 다형태의 제조방법
US20090247569A1 (en) * 2006-08-03 2009-10-01 Claude Singer Process for Preparing Clopidogrel Bisulphate
DK2064217T3 (da) 2006-09-04 2011-05-09 Ranbaxy Lab Ltd Forbedret fremgangsmåde til fremstilling af clopidogrel og dets farmaceutisk acceptable salte
EP1980563A1 (en) 2007-04-09 2008-10-15 BATTULA, Srinivasa Reddy Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
US20090264460A1 (en) * 2008-04-21 2009-10-22 Mamta Mishra Clopidogrel pharmaceutical formulations
KR100990949B1 (ko) 2008-06-09 2010-10-29 엔자이텍 주식회사 클로피도그렐 및 그의 유도체의 제조방법
EP2346879A1 (en) * 2008-10-24 2011-07-27 Sandoz AG A process for the preparation of s-clopidogrel
US8563690B2 (en) * 2008-11-03 2013-10-22 The Board Of Trustees Of The University Of Illinois Modulation of platelet aggregation
CN101544655B (zh) * 2009-05-05 2012-07-04 上海医药集团股份有限公司 噻吩并[3，2-c]吡啶衍生物的制备方法
CN101863899B (zh) * 2010-06-21 2013-03-20 常州制药厂有限公司 一种提高氯吡格雷樟脑磺酸盐拆分收率的方法
KR20170004282A (ko) 2015-07-02 2017-01-11 류종렬 수도 지지부가 구비된 쉐이크 핸드형 탁구 라켓
KR20170004283A (ko) 2015-07-02 2017-01-11 류종렬 그립부가 개선된 쉐이크 핸드형 탁구 라켓

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) * 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2608607B1 (fr) 1986-12-23 1989-04-28 Sanofi Sa Procede de preparation de thienylethylamines et dithienylethylamines ainsi obtenues
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2652575B1 (fr) * 1989-09-29 1992-01-24 Sanofi Sa Procede de preparation d'acides alpha-bromo phenylacetiques.
FR2664596B1 (fr) * 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.

Also Published As

Publication number Publication date
PT981529E (pt) 2002-06-28
AR014349A1 (es) 2001-02-28
CZ292820B6 (cs) 2003-12-17
HUP9700885A2 (hu) 1999-09-28
HUP9700885A3 (en) 2000-06-28
UA66359C2 (uk) 2004-05-17
MY121299A (en) 2006-01-28
ME01636B (me) 2007-08-03
YU58799A (sh) 2002-06-19
HUP9700885D0 (en) 1997-07-28
WO1998051689A1 (en) 1998-11-19
NO325419B1 (no) 2008-04-21
CN1255924A (zh) 2000-06-07
EE9900488A (et) 2000-06-15
AU735702B2 (en) 2001-07-12
ES2172141T3 (es) 2002-09-16
PL194859B1 (pl) 2007-07-31
ID23018A (id) 1999-12-30
HU222283B1 (hu) 2003-05-28
HK1027350A1 (en) 2001-01-12
KR100428238B1 (ko) 2004-04-30
TW552263B (en) 2003-09-11
HRP980240A2 (en) 1999-02-28
SK151699A3 (en) 2000-07-11
TR199902783T2 (xx) 2000-04-21
CZ393999A3 (cs) 2000-04-12
CA2289623A1 (en) 1998-11-19
IS1883B (is) 2003-08-15
BR9809112A (pt) 2000-08-01
CN1109036C (zh) 2003-05-21
US6180793B1 (en) 2001-01-30
SK283700B6 (sk) 2003-12-02
DE69803176D1 (de) 2002-02-21
NO995533D0 (no) 1999-11-12
AU7444898A (en) 1998-12-08
DZ2487A1 (fr) 2004-07-30
EP0981529A1 (en) 2000-03-01
JP4256478B2 (ja) 2009-04-22
SA98190583B1 (ar) 2006-08-19
EP0981529B1 (en) 2002-01-16
DE69803176T2 (de) 2002-08-22
RU2172315C1 (ru) 2001-08-20
RS49626B (sr) 2007-08-03
EE03925B1 (et) 2002-12-16
CO4950564A1 (es) 2000-09-01
CA2289623C (en) 2007-01-30
EG21973A (en) 2002-05-31
KR20010012511A (ko) 2001-02-15
IL132774A0 (en) 2001-03-19
BR9809112B1 (pt) 2010-10-05
ZA983921B (en) 1998-11-09
HRP980240B1 (en) 2003-02-28
PL336693A1 (en) 2000-07-03
IS5244A (is) 1999-11-11
JP2001525819A (ja) 2001-12-11
ATE212025T1 (de) 2002-02-15
NO995533L (no) 1999-12-13
NZ501577A (en) 2001-10-26

Similar Documents

Publication Publication Date Title
DK0981529T3 (da) Hidtil ukendt fremgangsmåde til fremstilling af farmakologisk aktivt stof
DK1032566T5 (da) Fremgangsmåde til fremstilling af citalopram
DK1005517T3 (da) Fremgangsmåde til fremstilling af diglycerider
DK1038008T3 (da) Fremgangsmåde til fremstilling af EGIII-lignende enzymer
DK1275387T3 (da) Fremgangsmåde til fremstilling af farmaceutiske præparater af fenofibrat med höj biologisk tilgængelighed
DK1123284T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1173431T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1105382T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1159274T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1032565T3 (da) Fremgangsmåde til fremstilling af derivater af taxoid-klassen
DK1040121T3 (da) Hidtil ukendt fremgangsmåde til fremstilling af cyclosporinderivater
DK1053217T3 (da) Fremgangsmåde til fremstilling af n-propanol
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
DK0970939T3 (da) Fremgangsmåde til fremstilling af methanol
DK2281892T3 (da) Fremgangsmåde til fremstilling af respiratorisk-deficiente Trichoderma-celler
DK0973769T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
DK0970073T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK1228056T3 (da) Fremgangsmåde til fremstilling af citalopram
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
DK0855379T3 (da) Fremgangsmåde til fremstilling af benzophenonderivater
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer
DK0893441T3 (da) Fremgangsmåde til fremstilling af pyridylmethylisothiocyanater
DK1177165T3 (da) Fremgangsmåde til fremstilling af pesticidmellemprodukter
DK1029867T3 (da) Fremgangsmåde til fremstilling af organiske azider